The duration of the trials varied: one lasted 26 weeks [25], four spanned 40 weeks [31,32,35,37], five extended to 52 weeks [29,30,33,34,36], and three covered 72 weeks [26-28]
Substancja musi by podawana do trzech razy w cigu doby
Author contributions JC: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Project administration, Resources, Software, Visualization, Writingoriginal draft, Writingreview and editing
J., & Deacon, C
Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society